Aerovate Therapeutics Stock Quote AVTE - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

1.81

Bid

1.82

Ask

1.88

Volume

449,151

1.78 Day's Range 1.915

1.25 52 Week Range 32.415

Market Cap

52.143M

Previous Close

1.82

Open

1.85

Last Trade

1.82

Last Trade Time

Financial Volume

$ 826,038

VWAP

1.8391

Average Volume (3m)

1,259,287

Shares Outstanding

28,808,334

Dividend Yield

PE Ratio

-0.69

Earnings Per Share (EPS)

-2.62

Revenue

Net Profit

-75.52M

Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hyper... Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.aerovatetx.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Aerovate Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AVTE. The last closing price for Aerovate Therapeutics was $1.82. Over the last year, Aerovate Therapeutics shares have traded in a share price range of $ 1.25 to $ 32.415.

Aerovate Therapeutics currently has 28,808,334 shares outstanding. The market capitalization of Aerovate Therapeutics is $52.43 million. Aerovate Therapeutics has a price to earnings ratio (PE ratio) of -0.69.

Can B Corp. Secures Ownership and Control of Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million

The Patents Term – Presumed Valid By Law – Extends to 2035 HICKSVILLE, NY -- March 11, 2024 -- InvestorsHub NewsWire -- Can B Corp., a Florida corporation (OTCQB: CANB...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.02	-1.09289617486	1.83	2.08	1.75	567842	1.93632237	CS
4	0.17	10.3658536585	1.64	2.08	1.57	572447	1.82150658	CS
12	-18.38	-91.0351659237	20.19	25.285	1.25	1259287	3.46084564	CS
26	-16.96	-90.3569525839	18.77	32.415	1.25	650411	5.90207938	CS
52	-15.66	-89.6393817974	17.47	32.415	1.25	363848	7.00549021	CS
156	-11.01	-85.8814352574	12.82	32.415	1.25	186513	10.85686426	CS
260	-26.19	-93.5357142857	28	32.415	1.25	184454	10.99177305	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NCNCnoco noco Inc	$ 0.28 (83.01%)	299.33M
WINTWindtree Therapeutics Inc	$ 9.19 (61.80%)	682.87k
NUZENuZee Inc	$ 5.915 (59.86%)	36.61M
PMECPrimech Holdings Ltd	$ 0.8299 (57.72%)	99.13M
LSHLakeside Holding Ltd	$ 3.70 (56.12%)	28.51M
CETUUCetus Capital Acquisition Corporation	$ 2.60 (-62.86%)	3.1k
CETUCetus Capital Acquisition Corporation	$ 2.22 (-62.18%)	537.72k
IMNNImunon Inc	$ 1.33 (-59.94%)	16.24M
FGENFibroGen Inc	$ 0.5417 (-47.41%)	16.48M
VCNXVaccinex Inc	$ 5.09 (-36.85%)	1.06M
NVDANVIDIA Corporation	$ 117.02 (12.81%)	473.28M
NCNCnoco noco Inc	$ 0.28 (83.01%)	299.32M
SQQQProShares UltraPro Short QQQ	$ 8.59 (-8.91%)	244.33M
PRSTPresto Technologies Inc	$ 0.038406 (9.73%)	207.12M
FFIEFaraday Future Intelligent Electric Inc	$ 0.343 (8.54%)	145.23M